๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells

โœ Scribed by Juan Du; Lin Li; Zhouluo Ou; Chenfei Kong; Yu Zhang; Zhixiong Dong; Shan Zhu; Hao Jiang; Zhimin Shao; Baiqu Huang; Jun Lu

Publisher
Springer US
Year
2011
Tongue
English
Weight
608 KB
Volume
131
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Ipriflavone inhibits osteolytic bone met
Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model
โœ Teruo Iwasaki; Mutsuko Mukai; Tohru Tsujimura; Masaharu Tatsuta; Hiroyuki Nakamu ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 274 KB

## Abstract Osteolytic bone metastasis is a frequent problem in the treatment of cancer. Ipriflavone, a synthetic isoflavone that inhibits osteoclastic bone resorption, has been used for the treatment of osteoporosis in some countries. Some other isoflavones also exhibit an antitumor effect __in vi

Targeted overexpression of BSP in osteoc
Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells
โœ Qisheng Tu; Jin Zhang; Amanda Fix; Erika Brewer; Yi-Ping Li; Zhi-yuan Zhang; Jak ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 782 KB

## Abstract Bone is one of the most common sites of breast cancer metastasis while bone sialoprotein (BSP) is thought to play an important role in bone metastasis of malignant tumors. The objective of this study is to determine the role of BSP overexpression in osteolytic metastasis using two homoz